Disrupting Drug Development through Crowdsourcing
Patients are consumers and today’s consumers are highly self-directed, research driven and actively use social media to navigate and chronicle their personal healthcare and treatment journeys. These global, detailed and candid exchanges create a brand-new data source that can be used to support multi-phases of drug development. Access to insights and the strategic use of social media can reduce drug development timelines, costs and accelerate access to new treatment options.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Larry Saltzman
Leukemia And Lymphoma Society
Kent Thoelke
PRA Health Sciences